Live Breaking News & Updates on Jazz pharmaceuticals company profile

Stay informed with the latest breaking news from Jazz pharmaceuticals company profile on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Jazz pharmaceuticals company profile and stay connected to the pulse of your community

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Acquired by Kendall Capital Management

Kendall Capital Management boosted its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 29.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,799 shares of the specialty pharmaceutical company’s stock after purchasing an additional 1,795 shares […]

United-states , Philipl-johnson , Robertw-baird , Patricia-carr , Needham-company , Barclays , Vanguard-group-inc , Jazz-pharmaceuticals , Aviva-plc , News-ratings-for-jazz-pharmaceuticals-daily , Jpmorgan-chase-co , Exchange-commission

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Purchased by Kendall Capital Management

Kendall Capital Management grew its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 29.9% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 7,799 shares of the specialty pharmaceutical company’s stock after buying an additional 1,795 shares during the quarter. Kendall Capital Management’s holdings in Jazz Pharmaceuticals were worth $959,000 […]

Wellington , New-zealand-general- , New-zealand , Canada , United-states , Patricia-carr , Stifel-nicolaus , Philipl-johnson , Jazz-pharmaceuticals-company-profile , Nasdaq , Jpmorgan-chase-co , News-ratings-for-jazz-pharmaceuticals-daily

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives $195.08 Average Price Target from Brokerages

Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have been given an average recommendation of “Moderate Buy” by the thirteen research firms that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The […]

United-states , Canada , Wellington , New-zealand-general- , New-zealand , Patricia-carr , Robertw-baird , Stifel-nicolaus , Philipl-johnson , Wellington-management-group , Jazz-pharmaceuticals-company-profile , Analyst-recommendations-for-jazz-pharmaceuticals

Jazz Pharmaceuticals plc to Post Q1 2024 Earnings of $3.24 Per Share, Zacks Research Forecasts (NASDAQ:JAZZ)

Jazz Pharmaceuticals plc to Post Q1 2024 Earnings of $3.24 Per Share, Zacks Research Forecasts (NASDAQ:JAZZ)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Utah , United-states , Philipl-johnson , Patricia-carr , Institutional-trading-of-jazz-pharmaceuticals , Jazz-pharmaceuticals-company-profile , Daiwa-securities-group-inc , Waterfront-wealth-inc , Zacks-research , Barclays , Jazz-pharmaceuticals-trading-down , News-ratings-for-jazz-pharmaceuticals-daily

Jazz Pharmaceuticals (NASDAQ:JAZZ) PT Raised to $190.00 at JPMorgan Chase & Co.

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its price objective lifted by equities research analysts at JPMorgan Chase & Co. from $170.00 to $190.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has an “overweight” rating on the specialty pharmaceutical company’s stock. JPMorgan Chase & Co.‘s target price […]

United-states , Stifel-nicolaus , Patricia-carr , Philipl-johnson , Covestor-ltd , Securities-exchange-commission , News-ratings-for-jazz-pharmaceuticals-daily , Jpmorgan-chase-co , Jazz-pharmaceuticals , Jazz-pharmaceuticals-trading , Analyst-recommendations-for-jazz-pharmaceuticals , Cantor-fitzgerald

Jazz Pharmaceuticals (NASDAQ:JAZZ) PT Raised to $190.00 at JPMorgan Chase & Co.

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its target price boosted by research analysts at JPMorgan Chase & Co. from $170.00 to $190.00 in a report released on Friday, Benzinga reports. The firm presently has an “overweight” rating on the specialty pharmaceutical company’s stock. JPMorgan Chase & Co.‘s price target suggests a potential upside […]

Canada , Blackrock , New-zealand-general- , New-zealand , Wellington , United-states , Patricia-carr , Philipl-johnson , Piper-sandler , Robertw-baird , Analyst-recommendations-for-jazz-pharmaceuticals , Jazz-pharmaceuticals-stock-performance

Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Raised to $190.00 at JPMorgan Chase & Co.

Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Raised to $190.00 at JPMorgan Chase & Co.
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Stifel-nicolaus , Philipl-johnson , Patricia-carr , Piper-sandler , Jpmorgan-chase-co , Assetmark-inc , Cantor-fitzgerald , Cape-investment-advisory-inc , Covestor-ltd , Securities-exchange-commission , Hedge-funds-weigh-in-on-jazz-pharmaceuticals

Needham & Company LLC Reiterates Buy Rating for Jazz Pharmaceuticals (NASDAQ:JAZZ)

Needham & Company LLC restated their buy rating on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) in a report released on Wednesday morning, Benzinga reports. Needham & Company LLC currently has a $220.00 target price on the specialty pharmaceutical company’s stock. JAZZ has been the subject of several other reports. Barclays reduced their price […]

Canada , Los-angeles , California , United-states , Blackrock , Philipl-johnson , Patricia-carr , Insider-transactions-at-jazz-pharmaceuticals , Barclays , News-ratings-for-jazz-pharmaceuticals-daily , Thompson-siegel-walmsley , Analyst-recommendations-for-jazz-pharmaceuticals

Jazz Pharmaceuticals (NASDAQ:JAZZ) Earns Buy Rating from Needham & Company LLC

Jazz Pharmaceuticals (NASDAQ:JAZZ) Earns Buy Rating from Needham & Company LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Los-angeles , California , United-states , Patricia-carr , Stifel-nicolaus , Philipl-johnson , Jazz-pharmaceuticals , Needham-company , News-ratings-for-jazz-pharmaceuticals-daily , Los-angeles-capital-management , Jazz-pharmaceuticals-stock-down , Cantor-fitzgerald

Jazz Pharmaceuticals' (JAZZ) "Overweight" Rating Reiterated at Cantor Fitzgerald

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report)‘s stock had its “overweight” rating reaffirmed by investment analysts at Cantor Fitzgerald in a report issued on Friday, Benzinga reports. They currently have a $180.00 price target on the specialty pharmaceutical company’s stock. Cantor Fitzgerald’s target price would suggest a potential upside of 47.22% from the company’s previous […]

United-states , Patricia-carr , Philipl-johnson , Robertw-baird , Advisor-group , Securities-exchange-commission , News-ratings-for-jazz-pharmaceuticals-daily , Vanguard-group-inc , Jazz-pharmaceuticals-stock-down , Barclays , Analyst-recommendations-for-jazz-pharmaceuticals , Institutional-trading-of-jazz-pharmaceuticals